U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.1133_1149del (p.Ala378fs) AND Monogenic diabetes

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 22, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003883153.1

Allele description [Variation Report for NM_000162.5(GCK):c.1133_1149del (p.Ala378fs)]

NM_000162.5(GCK):c.1133_1149del (p.Ala378fs)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.1133_1149del (p.Ala378fs)
Other names:
NM_000162.5(GCK):c.1133_1149del; p.Ala378fs
HGVS:
  • NC_000007.14:g.44145603_44145619del
  • NG_008847.2:g.57554_57570del
  • NM_000162.5:c.1133_1149delMANE SELECT
  • NM_001354800.1:c.1133_1149del
  • NM_001354801.1:c.122_138del
  • NM_001354802.1:c.-8_9del
  • NM_001354803.2:c.167_183del
  • NM_033507.3:c.1136_1152del
  • NM_033508.3:c.1130_1146del
  • NP_000153.1:p.Ala378fs
  • NP_001341729.1:p.Ala378fs
  • NP_001341730.1:p.Ala41fs
  • NP_001341731.1:p.Met1fs
  • NP_001341732.1:p.Ala56fs
  • NP_277042.1:p.Ala379fs
  • NP_277043.1:p.Ala377fs
  • LRG_1074t1:c.1133_1149del
  • LRG_1074t2:c.1136_1152del
  • LRG_1074:g.57554_57570del
  • LRG_1074p1:p.Ala378fs
  • LRG_1074p2:p.Ala379fs
  • NC_000007.13:g.44185202_44185218del
Protein change:
A377fs
Links:
dbSNP: rs1554334610
NCBI 1000 Genomes Browser:
rs1554334610
Molecular consequence:
  • NM_000162.5:c.1133_1149del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354800.1:c.1133_1149del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354801.1:c.122_138del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354802.1:c.-8_9del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354803.2:c.167_183del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033507.3:c.1136_1152del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033508.3:c.1130_1146del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354802.1:c.-8_9del - initiator_codon_variant - [Sequence Ontology: SO:0001582]

Condition(s)

Name:
Monogenic diabetes
Identifiers:
MONDO: MONDO:0015967; MedGen: C3888631

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004697899ClinGen Monogenic Diabetes Variant Curation Expert Panel
reviewed by expert panel

(ClinGen Monogenic Diabetes ACMG Specifications GCK V1.3.0)
Likely pathogenic
(Jan 22, 2024)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Monogenic Diabetes Variant Curation Expert Panel, SCV004697899.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.1133_1149del variant in the glucokinase gene, GCK, causes a frameshift in the protein at codon 378 (NM_000162.5), adding 75 novel amino acids before encountering a stop codon (p.(Ala378GlyfsTer75)). This variant, located in biologically-relevant exon 9 of 10, is predicted to lead to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMID: 19790256). This variant is absent in gnomAD v2.1.1 (PM2_Supporting). In summary, c.1133_1149del meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0, approved 8/11/2023): PVS1, PM2_supporting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024